1.Clinical, metabolic, and autoimmune characteristics of newly diagnosed young Filipino adults with diabetes mellitus.
Elizabeth Paz-Pacheco ; Angelique Bea C. Uy ; Angelique Love Tiglao-Gica ; Anna Elvira S. Arcellana ; Aura Bree Dayo-Lacdao ; Cynthia P. Cordero ; Cecilia A. Jimeno ; Ma. Cecille Añ ; onuevo-Cruz ; Noel R. Juban
Acta Medica Philippina 2026;60(2):41-49
OBJECTIVES
In Asia, younger individuals (below age 45) are diagnosed to have type 2 diabetes with increased rates of obesity defined by lower BMI yet with greater visceral adiposity (waist circumference and waisthip ratios). The prevalence data on type 1 diabetes is not well established, considered to be low, but is seen to be increasing as well. This changing phenotype therefore, presents a clinical dilemma in terms of correctly classifying diabetes and deciding on the consequent appropriate treatment. Distinguishing type 1 from type 2 diabetes has become more difficult with type 2 diabetes dramatically increasing in young adults and children. This study aims to define the characteristics of diabetes among young adults in the Philippines to provide a basis for appropriate management amidst changes in diabetes phenotypes seen globally.
METHODSIn this cross-sectional analytic study, we characterized the demographic, metabolic, and autoimmune features of diabetes among young adult Filipinos aged 18 to 45 years old consulting at a tertiary referral center in Manila, Philippines. Baseline serum A1c, FBS, 75-g oral glucose tolerance test, insulin, serum C-peptide, insulin autoantibodies, leptin, adiponectin, lipid profile, and thyroid function tests were obtained from the participants and analyzed. The homeostasis model assessment (HOMA) was used to estimate the insulin sensitivity.
RESULTSA total of 348 patients with diabetes were included, with females comprising two-thirds of the participants. The mean age at diagnosis of diabetes was 35.9±7.22 years. The mean BMI was 28.12 kg/m2, with median waist to hip ratio (WHR) of 0·93. Metabolic syndrome was found in 60% of participants and 67.82% were obese by body mass index. The mean A1c was 9.07±2.52%. Good glucose control (A1c less than 7.0%) was seen in 23% of participants while nearly half (48%) had HbA1c which was >9.0%. The median levels of fasting insulin and C-peptide were 12.62 (range 1.33–90.42) mIU/L and 0.78 ng/mL (range 0–16.2), respectively.
Included participants were diagnosed with diabetes within a year and as such, majority did not have any micro- or macrovascular complications. The most common diabetes complication was sensory neuropathy detected by monofilament testing, which was found in 28% of participants, followed by non-proliferative diabetic retinopathy in 13%. A history of previous diabetic ketoacidosis was found in 10 patients (2.87%). Glutamic acid decarboxylase (GAD) and insulin auto-antibodies were found in 3.2% and 19.3% of participants, respectively. Approximately half (51.73%) of the participants were insulin resistant by HOMA-IR.
CONCLUSIONIn contrast with Caucasians and other Asians, diabetes among young Filipino adults is associated with lower BMI but with a similarly high visceral adiposity as shown by an elevated WHR. Metabolic syndrome with insulin resistance as defined by a variety of indices is predominant. Type 1 diabetes with autoantibodies occur in only a small fraction of this population. Data derived from this work can provide a framework for cluster analysis towards personalized management specific to this population.
Human ; Acids ; Adiponectin ; Adiposity ; Adult ; Aged ; Antibodies ; Asia ; Asian ; Asian Continental Ancestry Group ; Autoantibodies ; Body Mass Index ; C-peptide ; Carboxy-lyases ; Child ; Cluster Analysis ; Demography ; Diabetes Complications ; Diabetes Mellitus ; Diabetes Mellitus, Type 1 ; Diabetes Mellitus, Type 2 ; Diabetic Ketoacidosis ; Diabetic Retinopathy ; Diagnosis ; Fasting ; Female ; Glucose ; Glucose Tolerance Test ; Glutamate Decarboxylase ; Glutamic Acid ; Insulin ; Insulin Resistance ; Ketosis ; Leptin ; Lipids ; Metabolic Syndrome ; Obesity ; Patients ; Peptides ; Phenotype ; Philippines ; Population ; Prevalence ; Serum ; Therapeutics ; Thyroid Gland ; Thyroid Function Tests ; Young Adult
2.Effects of Garcinia mangostana Peel Extract on Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review of Human Studies
Yosef Purwoko ; K Heri Nugroho ; Siti Setiati ; Banundari Rachmawati
Acta Medica Indonesiana 2026;58(1):52-58
Abstract
Introduction: Type 2 diabetes mellitus (T2DM) is a major global health concern characterized by insulin resistance, hyperglycemia, and chronic inflammation. Interest in natural adjunctive therapies has increased, particularly in mangosteen (Garcinia mangostana), which contains xanthone compounds in the peel with potential antidiabetic properties. Methods: This systematic review followed PRISMA 2020 guidelines. Literature searches were conducted using PubMed, Google Scholar, and ClinicalKey up to December 2022 for studies assessing mangosteen peel extract (MPE) or α-mangostin in diabetic human subjects. Eligible studies included randomized controlled and quasi-experimental trials reporting glycemic or metabolic outcomes. Risk of bias was evaluated using the Cochrane RoB tool. The primary result of this study is to evaluate the effects of mangosteen peel extract supplementation on key glycemic outcomes in patients with T2DM, specifically fasting blood glucose (FBG), HOMA-IR, and HbA1c. Results: A total of two studies (n=2) met the inclusion criteria. A randomized controlled pilot trial reported significant improvement in insulin sensitivity (HOMA-IR −53.2% vs −15.2%; p = 0.004) after 26 weeks of standardized mangosteen extract. A small quasi-experimental study reported a significant reduction in FBG following 7 days of mangosteen peel decoction. Discussion: Limited clinical evidence indicates that mangosteen peel extract may improve insulin sensitivity and lower fasting glucose in T2DM. However, the conclusions are limited by the small number of available studies, the short follow-up duration in one trial, and variability in extract preparation. Conclusion: Mangosteen peel extract demonstrates promising glycemic benefits, including improved insulin sensitivity and reduced fasting glucose. However, the available evidence remains limited by small sample sizes, short follow-up periods, and heterogeneity in extract formulations. Larger randomized controlled trials using standardized preparations are required before clinical recommendations can be made.
Garcinia mangostana
;
mangosteen peel extract
;
&alpha
;
-mangostin
;
type 2 diabetes mellitus
;
insulin resistance
;
oxidative stress
3.Association of Testosterone With Insulin Resistance and Beta-Cell Function in Type 2 Diabetes Mellitus
Khoirun Mukhsinin Putra ; Yulianto Kusnadi ; Ratna Maila Dewi ; Alwi Shahab
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):56-57
Introduction:
Insulin resistance and progressive beta-cell dysfunction
are key components of the pathophysiology of type
2 diabetes mellitus (T2DM). The triglyceride-to-highdensity lipoprotein cholesterol (TG/HDL) ratio has been
widely used as a marker of insulin resistance. In addition,
testosterone deficiency has been associated with adverse
metabolic profiles and T2DM. However, the relationship
between testosterone levels, insulin resistance, and betacell function in patients with T2DM remains incompletely
understood.
Methodology:
A cross-sectional study was conducted involving 25 male
patients with T2DM attending the diabetic clinic at Dr.
Mohammad Hoesin General Hospital. Serum testosterone,
C-peptide, TG, and HDL levels were obtained from routine
clinical data. The TG/HDL ratio was calculated as an index
of insulin resistance. Normality was assessed using the
Shapiro–Wilk test, and due to the non-normal distribution
of key variables, Spearman correlation analysis was
applied.
Results:
A strong inverse correlation was observed between
testosterone levels and TG/HDL ratio (r = -0.860, p <0.001),
indicating that higher insulin resistance was associated
with lower testosterone levels. In addition, TG/HDL ratio
showed a strong negative correlation with C-peptide levels
(r = -0.741, p <0.001), suggesting reduced beta-cell function
in the presence of increased insulin resistance.
Conclusion
In patients with T2DM, increased insulin resistance is
strongly associated with lower testosterone levels and
reduced beta-cell function. These findings highlight the
interaction between metabolic dysfunction and hormonal
status in middle-aged and elderly patients with T2DM
Diabetes Mellitus, Type 2
;
Insulin Resistance
;
Testosterone
4.When Hypoglycemia Speaks Louder Than the Chest: A Decade-Late Recurrence of IGF-2-Mediated Non-Islet Cell Tumor Hypoglycemia
Li Li Kwan ; Deviga Lachumanan
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):67-68
Introduction:
Non-islet cell tumor hypoglycemia (NICTH) is a rare
paraneoplastic syndrome caused by tumor secretion of
insulin-like growth factor-2 (IGF-2), leading to recurrent
hypoinsulinemic hypoglycemia. It is most commonly
associated with large mesenchymal tumors, such as solitary fibrous tumor, particularly those arising from the pleura
or lungs. This phenomenon, also known as Doege–Potter
syndrome, may precede tumor detection or signal tumor
recurrence. We report a striking case of late malignant
recurrence presenting solely with hypoglycemia after
a decade of remission.
Case:
A 68-year-old female was initially presented in 2016
with respiratory symptoms and recurrent symptomatic
fasting and post-prandial hypoglycemia, and was found
to have a large left upper lobe mass. Tumor resection in
2017 resulted in complete resolution of hypoglycemia.
She remained asymptomatic for several years. In
2023, she developed recurrent hypoglycemia without
respiratory or constitutional symptoms. Biochemical
evaluation demonstrated hypoinsulinemic hypoglycemia
with suppressed insulin and C-peptide, low IGF-1, and
markedly elevated IGF-2, resulting in an IGF-2:IGF-1 ratio
of 25, consistent with IGF-2-mediated NICTH. Computed
tomography imaging revealed a large left thoracic mass
with invasion into the intercostal muscles and diaphragm
with extension toward the stomach, associated with
contralateral lung nodules and possible liver metastases,
suggesting recurrent malignant disease. Hypoglycemia
improved with glucocorticoid therapy, and the patient
was referred for oncological assessment. Despite initiation
of systemic chemotherapy, her disease progressed and she
succumbed during treatment.
Conclusion
This case highlights several important lessons: Firstly,
recurrent hypoinsulinemic hypoglycemia warrants
evaluation for NICTH even in the absence of tumor-related
symptoms. Secondly, solitary fibrous tumors may recur
or undergo malignant transformation after prolonged
disease-free intervals; and glucocorticoids provide effective
metabolic control but do not alter oncologic prognosis.
Long-term surveillance should be considered in patients
with prior solitary fibrous tumors due to the risk of delayed
recurrence and paraneoplastic complications.
Insulin-Like Growth Factor II
;
Hypoglycemia
;
Neoplasms
5.When IGF-1 Misleads: Discordant Biochemical Findings in Acromegaly
Ashwini Chandrasekaran ; Subashini Rajoo ; Gayathri Devi Krishnan ; Shazatul Reza ; Sharifah Noor Adrilla ; Xe Hui Lee
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):90-
Introduction:
Acromegaly is an endocrine disorder caused by excess
growth hormone (GH), causing somatic overgrowth,
multiple comorbidities, and premature mortality. It is
confirmed biochemically by an elevated GH level, which
is not suppressed post oral glucose tolerance test (OGTT).
The serum level of insulin-like growth factor-1 (IGF-1) is
recommended for diagnosis, monitoring, and screening,
and a normal level effectively excludes the disease. We
report a patient with acromegaly who presented with
normal IGF-1.
Case:
A 21-year-old female, with no known medical illness,
presented with a persistent, progressive headache and
amenorrhea for the past 6 months. She also noticed
a change in facial appearance and an increase in the
size of her hands and feet. Blood parameters revealed
raised GH level of >50 ng/mL, normal IGF-1 30.3 nmol/L
(12.17–44.80), mildly raised prolactin 692 mIU/L, low am
cortisol 62 nmol/L (166–507), thyroid-stimulating hormone
of 0.63 mIU/L (0.27–4.20), free thyroxine 4 11 pmol/L
(12–22), low follicle-stimulating hormone 0.90 IU/L,
luteinizing hormone <0.30 IU/L, estradiol <18.4 pmol/L,
and fasting blood sugar of 17.7 mmol/L with hemoglobin
A1c 9%. In view of normal IGF-1 with a high index of
suspicion for acromegaly, she underwent OGTT which
showed unsuppressed GH. Magnetic resonance imaging
pituitary showed sellar mass 2.4 × 2.9 × 2.1 cm with
suprasellar extension as well as extension into the right
cavernous sinus, suggestive of pituitary macroadenoma.
She was diagnosed with acromegaly with secondary
adrenal insufficiency and central hypothyroidism with
hypogonadotropic hypogonadism, complicated with
poorly controlled diabetes. She was started on thyroxine
and hydrocortisone replacement and required basal bolus
insulin of 1.3 u/kg/day. Repeated IGF-1 showed a raised value, 85.4 nmol/L, after optimization of diabetes. She
underwent endoscopic transsphenoidal surgery with
normalization of blood sugar post-surgery. Blood pressure
was normal throughout.
Conclusion
False negative or normal IGF-1 levels may result in patients
with hepatic or renal failure, hypothyroidism, malnutrition, use of oral estrogen, severe infection, and poorly
controlled diabetes mellitus. Hence, a low or normal IGF1 does not exclude acromegaly in patients with a high
index of suspicion and warrants further investigation.
Acromegaly
;
Insulin-Like Growth Factor I
6.Biochemical Discordance in Acromegaly Complicated by Pituitary Apoplexy and Severe Insulin Resistance
Jean Mun Cheah ; Fei Bing Yong ; K.J. Lingeswary ; Jen Hoong Oon ; Sharifah Noor Adrilla binti Long Mohd Noor Affendi ; Gayathri Devi A/P Krishnan ; Shazatul Reza binti Mohd Redzuan ; Subashini Rajoo
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):100-
Introduction:
Acromegaly is usually diagnosed by elevated age- and
sex-adjusted insulin-like growth factor-1 (IGF-1) levels
reflecting chronic growth hormone (GH) excess. IGF-1 is
preferred as a screening biomarker due to its longer half-life
and reduced pulsatility compared with GH. However, IGF1 levels may be disproportionately low or only modestly
elevated in certain clinical contexts, leading to diagnostic
uncertainty. Pituitary apoplexy is one such condition in
which acute tumor hemorrhage or infarction may disrupt
sustained GH secretion and attenuate IGF-1 production
Case:
A 48-year-old female with hypertension, type 2 diabetes
mellitus, and dyslipidemia presented with a 2-day history
of severe headache, vomiting, and visual disturbance, on a
background of progressive acral enlargement over 2 years.
Examination revealed coarse facial features, prognathism,
enlarged hands, and cranial nerve involvement. Magnetic
resonance imaging demonstrated an invasive sellar–
suprasellar pituitary macroadenoma with optic chiasmal
compression and cavernous sinus encasement. Intravenous
dexamethasone was initiated pre-operatively due to a
significant mass effect.
Biochemical evaluation showed markedly elevated
random GH levels (>50 ng/mL) with only mildly elevated
IGF-1 at 1.19 times the upper limit of normal, below the
threshold at which confirmatory oral glucose tolerance
testing may be omitted according to current guidelines.
Other pituitary axes suggested evolving hypopituitarism.
During admission, she developed severe hyperglycemia
with marked insulin resistance, requiring high-dose insulin
therapy (approximately 1.5 U/kg/day). She underwent
urgent transsphenoidal surgery, with histopathology
confirming a pituitary neuroendocrine tumor with extensive
hemorrhage and infarction, consistent with pituitary
apoplexy. Postoperatively, GH levels were suppressed to
<5 ng/mL, insulin requirements decreased markedly, and
hormone replacement was initiated for secondary adrenal
insufficiency and central hypothyroidism.
Conclusion
This case highlights that IGF-1 levels below conventional
diagnostic thresholds do not exclude clinically significant
acromegaly, particularly in the setting of pituitary
apoplexy. Integration of clinical phenotype, GH levels, and
imaging findings is essential to avoid diagnostic delay and
ensure timely management.
Acromegaly
;
Insulin Resistance
;
Pituitary Apoplexy
7.Novel araucarene diterpenes from Agathis dammara exert hypoglycemic activity by promoting pancreatic β cell regeneration and glucose uptake.
Zhewei YU ; Yi ZHANG ; Wenhui WANG ; XinYi WU ; Shunzhi LIU ; Yanlin BIN ; Hongsheng LI ; Bangping CAI ; Zheng WANG ; Meijuan FANG ; Rong QI ; Mingyu LI ; Yingkun QIU
Chinese Journal of Natural Medicines (English Ed.) 2025;23(4):492-503
In this study, araucarene diterpenes, characterized by a pimarene skeleton with a variably oxidized side chain at C-13, were investigated. A total of 16 araucarene diterpenoids and their derivatives were isolated from the woods of Agathis dammara, including 11 previously unreported compounds: dammaradione (1), dammarones D-G (2, 5, 14, 15), dammaric acids B-F (8-12), and dammarol (16). The structures of these new compounds were elucidated using high-resolution electrospray ionization mass spectroscopy (HR-ESI-MS) and one-dimensional/two-dimensional (1D/2D) nuclear magnetic resonance (NMR), while their absolute configurations were determined through the electronic circular dichroism (ECD) exciton chirality method and Snatzke's method. The hypoglycemic activity of all isolated compounds was evaluated using a transgenic zebrafish model, and a structure-activity relationship (SAR) analysis was conducted. Araucarone (3) and dammaric acid C (9), serving as representative compounds, demonstrated significant hypoglycemic effects on zebrafish. The primary mechanism involves the promotion of pancreatic β cell regeneration and glucose uptake. Specifically, these compounds enhance the differentiation of pancreatic endocrine precursor cells (PEP cells) into β cells in zebrafish.
Zebrafish
;
Animals
;
Diterpenes/isolation & purification*
;
Insulin-Secreting Cells/cytology*
;
Glucose/metabolism*
;
Hypoglycemic Agents/isolation & purification*
;
Molecular Structure
;
Structure-Activity Relationship
;
Plant Extracts/pharmacology*
;
Regeneration/drug effects*
8.The transcriptomic-based disease network reveals synergistic therapeutic effect of total alkaloids from Coptis chinensis and total ginsenosides from Panax ginseng on type 2 diabetes mellitus.
Qian CHEN ; Shuying ZHANG ; Xuanxi JIANG ; Jie LIAO ; Xin SHAO ; Xin PENG ; Zheng WANG ; Xiaoyan LU ; Xiaohui FAN
Chinese Journal of Natural Medicines (English Ed.) 2025;23(8):997-1008
Coptis chinensis Franch. and Panax ginseng C. A. Mey. are traditional herbal medicines with millennia of documented use and broad therapeutic applications, including anti-diabetic properties. However, the synergistic effect of total alkaloids from Coptis chinensis and total ginsenosides from Panax ginseng on type 2 diabetes mellitus (T2DM) and its underlying mechanism remain unclear. The research demonstrated that the optimal ratio of total alkaloids from Coptis chinensis and total ginsenosides from Panax ginseng was 4∶1, exhibiting maximal efficacy in improving insulin resistance and gluconeogenesis in primary mouse hepatocytes. This combination demonstrated significant synergistic effects in improving glucose tolerance, reducing fasting blood glucose (FBG), the weight ratio of epididymal white adipose tissue (eWAT), and the homeostasis model assessment of insulin resistance (HOMA-IR) in leptin receptor-deficient (db/db) mice. Subsequently, a T2DM liver-specific network was constructed based on RNA sequencing (RNA-seq) experiments and public databases by integrating transcriptional properties of disease-associated proteins and protein-protein interactions (PPIs). The network recovery index (NRI) score of the combined treatment group with a 4∶1 ratio exceeded that of groups treated with individual components. The research identified that activated adenosine 5'-monophosphate-activated protein kinase (AMPK)/acetyl-CoA carboxylase (ACC) signaling in the liver played a crucial role in the synergistic treatment of T2DM, as verified by western blot experiment in db/db mice. These findings demonstrate that the 4∶1 combination of total alkaloids from Coptis chinensis and total ginsenosides from Panax ginseng significantly improves insulin resistance and glucose and lipid metabolism disorders in db/db mice, surpassing the efficacy of individual treatments. The synergistic mechanism correlates with enhanced AMPK/ACC signaling pathway activity.
Animals
;
Panax/chemistry*
;
Ginsenosides/administration & dosage*
;
Diabetes Mellitus, Type 2/metabolism*
;
Mice
;
Male
;
Alkaloids/pharmacology*
;
Coptis/chemistry*
;
Drug Synergism
;
Insulin Resistance
;
Mice, Inbred C57BL
;
Humans
;
Transcriptome/drug effects*
;
Blood Glucose/metabolism*
;
Hypoglycemic Agents/administration & dosage*
;
Drugs, Chinese Herbal/administration & dosage*
;
Hepatocytes/metabolism*
9.Life-Course Trajectories of Body Mass Index, Insulin Resistance, and Incident Diabetes in Chinese Adults.
Zhi Yuan NING ; Jing Lan ZHANG ; Bing Bing FAN ; Yan Lin QU ; Chang SU ; Tao ZHANG
Biomedical and Environmental Sciences 2025;38(6):706-715
OBJECTIVE:
This study aimed to explore the interplay between the life-course body mass index (BMI) trajectories and insulin resistance (IR) on incident diabetes.
METHODS:
This longitudinal cohort included 2,336 participants who had BMI repeatedly measured 3-8 times between 1989 and 2009, as well as glucose and insulin measured in 2009. BMI trajectories were identified using a latent class growth mixed model. The interplay between BMI trajectories and IR on diabetes was explored using the four-way effect decomposition method. Logistic regression and mediation models were used to estimate the interaction and mediation effects, respectively.
RESULTS:
Three distinct BMI trajectory groups were identified: low-stable ( n = 1,625), medium-increasing ( n = 613), and high-increasing ( n = 98). Both interaction and mediation effects of BMI trajectories and IR on incident diabetes were significant ( P < 0.05). The proportion of incident diabetes was higher in the IR-obesity than in the insulin-sensitivity (IS) obesity group (18.9% vs. 5.8%, P < 0.001). After adjusting for covariates, the odds ratios (95% confidence intervals) of the IR, IS-obesity, and IR-obesity groups vs. the normal group were 3.22 (2.05, 5.16), 2.05 (1.00, 3.97), and 7.98 (5.19, 12.62), respectively. IR mediated 10.7% of the total effect of BMI trajectories on incident diabetes ( P < 0.001).
CONCLUSION
We found strong interactions and weak mediation effects of IR on the relationship between life-course BMI trajectories and incident diabetes. IS-obesity is associated with a lower risk of incident diabetes than IR-obesity.
Humans
;
Insulin Resistance
;
Body Mass Index
;
Male
;
Female
;
Middle Aged
;
China/epidemiology*
;
Adult
;
Longitudinal Studies
;
Incidence
;
Diabetes Mellitus/epidemiology*
;
Aged
;
Obesity/epidemiology*
;
Diabetes Mellitus, Type 2/epidemiology*
;
East Asian People
10.Research Progress on Obesity-Associated Kidney Diseases.
Rui-Feng YANG ; Wen WU ; Peng ZHANG
Acta Academiae Medicinae Sinicae 2025;47(1):77-85
The pathogenesis of obesity-associated kidney disease (OAKD) involves many aspects,including the overactivation of the renin-angiotensin-aldosterone system,insulin resistance,chronic inflammation,disorder of lipid metabolism and imbalance of gut microecology.Treatment strategies for OAKD focus on lifestyle adjustments,pharmacotherapy,bariatric surgery,and fecal microbiota transplantation.A deeper understanding of the hazards of OAKD and its pathogenesis will contribute to the development of personalized and precise strategies for prevention,diagnosis and treatment of OAKD in the future.
Humans
;
Obesity/complications*
;
Kidney Diseases/therapy*
;
Renin-Angiotensin System
;
Insulin Resistance


Result Analysis
Print
Save
E-mail